» Articles » PMID: 19640984

The Human Papillomavirus (HPV) E6* Proteins from High-risk, Mucosal HPVs Can Direct Degradation of Cellular Proteins in the Absence of Full-length E6 Protein

Overview
Journal J Virol
Date 2009 Jul 31
PMID 19640984
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The E6 oncoproteins from high-risk mucosotrophic human papillomaviruses (HPVs) target a range of cellular proteins for proteasome-mediated degradation. Apart from the tumor suppressor p53 and proapoptotic Bcl-2 family member Bak, many targets contain class 1 PDZ domains and are involved in cell junction stability and signaling. The targeting mechanism is considered to function by the E6 protein acting as an adaptor molecule linking a cellular ubiquitin ligase to the target protein. In each case, whether the target is the p53 tumor suppressor or a member of the group of PDZ domain-containing targets, this mechanism relies on a direct interaction between E6 and its cellular target. This study focuses on the impact of the HPV type 18 (HPV-18) E6*I protein on the stability of Akt, Dlg, MAGI-1, MAGI-2, and Scribble. We show that HPV-18 E6* expression can downregulate the expression levels of Akt, Dlg, and Scribble in the absence of full-length HPV-18 E6 protein. The reduction in Dlg levels by E6* is independent of transcription and does not require a direct interaction between the two proteins although the proteasome pathway is involved. Further, we provide evidence that activation of certain signal transduction pathways has a profound effect on the targeting of Dlg by E6* and suggest that high-risk HPV E6 oncoproteins can target certain substrates both directly and indirectly through the E6* proteins and may cooperate in their degradation.

Citing Articles

Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?.

Kathleen W Tumour Virus Res. 2024; 19():200311.

PMID: 39733972 PMC: 11753912. DOI: 10.1016/j.tvr.2024.200311.


Alternative splicing in the genome of HPV and its regulation.

Wang Y, Chen F, Qu W, Gong Y, Wang Y, Chen L Front Cell Infect Microbiol. 2024; 14:1443868.

PMID: 39502170 PMC: 11534716. DOI: 10.3389/fcimb.2024.1443868.


HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype.

Zhitkevich A, Bayurova E, Avdoshina D, Zakirova N, Frolova G, Chowdhury S Viruses. 2024; 16(2).

PMID: 38399969 PMC: 10892743. DOI: 10.3390/v16020193.


HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.

Peng Q, Wang L, Zuo L, Gao S, Jiang X, Han Y Cancer Gene Ther. 2023; 31(1):9-17.

PMID: 38102462 DOI: 10.1038/s41417-023-00682-3.


HPV transcript expression affects cervical cancer response to chemoradiation.

Ruiz F, Inkman M, Rashmi R, Muhammad N, Gabriel N, Miller C JCI Insight. 2021; 6(16).

PMID: 34255749 PMC: 8409981. DOI: 10.1172/jci.insight.138734.


References
1.
Gardiol D, Kuhne C, Glaunsinger B, Lee S, Javier R, Banks L . Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene. 1999; 18(40):5487-96. DOI: 10.1038/sj.onc.1202920. View

2.
Chen J, Reid C, Band V, Androphy E . Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science. 1995; 269(5223):529-31. DOI: 10.1126/science.7624774. View

3.
Mantovani F, Banks L . The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001; 20(54):7874-87. DOI: 10.1038/sj.onc.1204869. View

4.
Tomaic V, Gardiol D, Massimi P, Ozbun M, Myers M, Banks L . Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene. 2008; 28(1):1-8. PMC: 3569523. DOI: 10.1038/onc.2008.365. View

5.
Smotkin D, WETTSTEIN F . Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci U S A. 1986; 83(13):4680-4. PMC: 323805. DOI: 10.1073/pnas.83.13.4680. View